Ultra-thin strut thickness of 65 um, for significant reduction of angiographic & clinical restenosis and reduces arterial injury
With lower profile and smaller stent volume, Everoshine has inherent characteristics of improved flexibility and deliverability, thus navigating its path to the smaller and torturous vessels.
Thin polymer thickness of 1.5 u reduces the Tissue-polymer contact and eventually reduces the polymer related disadvantages like inflammation.
The coating process allows the integrity of coated polymer after excessive stent expansion and a systemic elution of Everolimus in a well-controlled fashion after the stent implantation.
The stent has features like great flexibility, crossability and conformability.
53 year old male patient with SVD-LAD-D1 bifurcation lesion with > 70% stenosis in target lesion with chance of losing a significant side branch. With Everoshine stent the side branch stenting was successfully completed with resultant TIMI flow of grade 3.
71 years old female patient with diabetes and Hypertension with tight and calcified LAD lesions with 80% of stenosis. Overlapping stent implantation was successfully completed in mid-LAD with Everoshine stent without any MACE.
Please complete and submit the form below. A member of our team will be in touch shortly to confirm the booking.
Innovative Stent Design with proven blend of anti-proliferative Drug sirolimus & Bioresorbable Polymers, Contributing to exceptional Acute & Long term Performance
Stay up to date with our Editor's Picks newsletter.